“…Sorting out scientific fact from marketing “spin” can be challenging to say the least (e.g., Vedantam, 2001). As professional psychology moves into a new era of prescription privileges (Daw, 2002), it will likely receive increasing direct financial and marketing attention from the pharmaceutical industry (Antonuccio, Burns, & Danton, 2002; Beutler, 2002), causing potential conflicts of interest that may affect the scientific database. Opponents of prescription privileges argue that our profession will be harmed by these influences (Antonuccio & Danton, 2003), whereas proponents argue that our high scientific standards will protect us (Levant & Sammons, 2003).…”